| Identification | Back Directory | [Name]
3'-DC CEP | [CAS]
157327-96-3 | [Synonyms]
3'-DC CEP
3'-dC-CE Phosphoramidite
3'-dC(Bz)-2'-phosphor amidite
N6-Benzoyl-5'-O-DMT-3'-deoxycytidine 2'-CE phosphoramidite
N6-Benzoyl-3'-deoxy-5'-O-DMT-cytidine 2'-CE phosphoramidite
N4-Benzoyl-5’-O-(4,4-dimethoxytrityl)-3’-deoxycytidine-2’-CED-phosphoramidite
5'-Dimethoxytrityl-N-benzoyl-3'-deoxyCytidine,2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
4-N-benzoyl-3'-deoxy-5'-O-(4,4'-dimethoxytrityl)cytidine 2-cyanoethyl N,N-diisopropylphosphoramidite
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxycytidine 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy-, 2'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) | [Molecular Formula]
C46H52N5O8P | [MDL Number]
MFCD08062013 | [MOL File]
157327-96-3.mol | [Molecular Weight]
833.91 |
| Hazard Information | Back Directory | [Uses]
3’-dC(Bz)-2’-phosphor amidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|